Top Markets
Coin of the day
NurExone Biologic Inc. NurExone Biologic Inc.

NurExone Biologic Inc.

NRX
Rank in Stocks #27129
NurExone Biologic Inc., a pharmaceutical technology company, develops a... NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
Share Price
$0.47705898
Last synced: 2026-08-19
Market Cap
$35.01M
Change (1 day)
8.33%
Change (1 year)
-16.23%
Country
CA
Trade NurExone Biologic Inc. (NRX)

Category

EPS for NurExone Biologic Inc. (NRX)
EPS as of 2026 TTM: 0
According to NurExone Biologic Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for NurExone Biologic Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$-7.98 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH